| Names | |
|---|---|
| Preferred IUPAC name N,N,N-Trimethyl-3-{[ethoxy(methylphosphonoyl)]oxy}-5-{3-[3-(trimethylazaniumyl)phenoxy]propoxy}anilinium bis(tetraphenylboranuide) | |
| Identifiers | |
3D model (JSmol) | |
| |
| |
| Properties | |
| C72H79B2N2O5P | |
| Molar mass | 1105.03 g·mol−1 |
| Appearance | Solid |
| Melting point | 108–111 °C (226–232 °F; 381–384 K) |
| Insoluble | |
| Solubility | Soluble in acetone |
| Hazards | |
| Occupational safety and health (OHS/OSH): | |
Main hazards | Extremely toxic |
| Lethal dose or concentration (LD, LC): | |
LD50 (median dose) | 20 μg/kg (Rats, IV) 6.7 μg/kg (Rabbits, IV) |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
EA-2098 is an extremely toxicorganophosphatenerve agent. It is an extremely potentacetylcholinesterase inhibitor that is resistant toatropine and oxime treatment.[1]
EA-2098 was developed as part of a series of "V-series" nerve agents researched for military applications.[2]